Catalyst Wire Dossier Catalyst Wire Dossier

BONCRESA

denosumab-mobz · Amneal Pharmaceuticals LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BONCRESA, covering 2025-12-19 to 2025-12-19. Get the full timeline:

Most recent: FDA Approved: BONCRESA — Original Application (Amneal Pharmaceuticals LLC)

See pricing